Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics

Παρόμοια τεκμήρια

• Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia
  ανά: Sliwa, Jennifer Kern, κ.ά.
  Έκδοση: (2012)
• Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trial
  ανά: Bossie, Cynthia A., κ.ά.
  Έκδοση: (2011)
• Comparing Injection Site Pain with Paliperidone Palmitate Versus First-Generation Depot Antipsychotics in Subjects with Schizophrenia
  ανά: Gopal, Srihari, κ.ά.
  Έκδοση: (2015)
• Treatment effect with paliperidone palmitate compared with oral antipsychotics in patients with recent‐onset versus more chronic schizophrenia and a history of criminal justice system involvement
  ανά: Alphs, Larry, κ.ά.
  Έκδοση: (2015)
• Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database
  ανά: Voss, Erica A., κ.ά.
  Έκδοση: (2015)